TAG: vaccins Immunogenicity and Reactogenicity of Messenger RNA Coronavirus Disease 2019 Vaccine Booster Administered by Intradermal or Intramuscular Route in Thai Older Adults. Assantachai P, et al, J Infect Dis 2023.08 Jan 2024 à 04:07 -- Mon Jan 8 04:07:07 2024 No Immunological Interference or Safety Concerns When Adjuvanted Recombinant Zoster Vaccine Is Coadministered With a Coronavirus Disease 2019 mRNA-1273 Booster Vaccine in Adults Aged 50 Years and Older: A Randomized Trial. Naficy A, et al, Clin Infect Dis 2023.15 Dec 2023 à 04:07 -- Fri Dec 15 04:07:09 2023 Protecting Nursing Homes and Long-Term Care Facilities From COVID-19: A Rapid Review of International Evidence. Dykgraaf SH, et al, J Am Med Dir Assoc 2021.19 Jun 2023 à 22:49 -- Mon Jun 19 22:49:55 2023 Safety, immunogenicity and immune-persistence of heterologous prime-boost immunization with BBIBP-CorV and ZF2001 against SARS-CoV-2 in healthy adults aged 18 years or older. Chen Y, et al, Expert Rev Vaccines 2023.27 Mar 2024 à 07:07 -- Wed Mar 27 07:07:13 2024 S'identifier